Literature DB >> 14608840

[Manifestations of hemorrhagic fever with renal syndrome in a military unit stationed in a combat zone].

Slavisa Cirić1, Vesna Denić, Vekoslav Mitrović, Natasa Mitrović-Perisić, Nebojsa Denić, Slobodan Cirić.   

Abstract

Since it has been recognized as a separate disease during the Korean war, hemorrhagic fever with renal syndrome (HFRS) has often been discovered among the members of different armies in various countries, military personnel being the highest risk group for the disease. In the period from March to May 1999 we treated 6 soldiers coming from the military formation stationed at Kosovo and Metohia. The reaction of indirect hemagglutination test proved the presence of antibodies against Hantavira in each of them. They were infected during the stay in a dugout in the area with great population of field rodents. Only one patient was slightly ill, on the admission to the hospital. The others had severe clinical and laboratory findings: several days lasting fever, strong abdominal pain, as well as the pain in the loins, dyspeptical discomfort, manifold increased blood urea nitrogen and serum creatinine values, thrombocytopenia, etc. Oliguria occurred in 4 patients. Hemorrhagic manifestations were slight (epistaxis, petechial rash, conjunctival injection), or absent. Because of the aggravation of the acute renal failure, hemodialysis was performed in 3 patients, while other 3 underwent conservative treatment. Two of the patients had severe anemia because of which transfusions of erythrocytes and plasma were performed. Complications occurred in 2 patients (convulsive crises and lung infections). All patients recovered completely.

Entities:  

Mesh:

Year:  2003        PMID: 14608840     DOI: 10.2298/vsp0305605c

Source DB:  PubMed          Journal:  Vojnosanit Pregl        ISSN: 0042-8450            Impact factor:   0.168


  1 in total

1.  Hypopituitarism as a late complication of hemorrhagic fever.

Authors:  Sandra Pekic; Goran Cvijovic; Marko Stojanovic; Aleksandra Kendereski; Dragan Micic; Vera Popovic
Journal:  Endocrine       Date:  2005-03       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.